Deep Tech Startups

Martian is an AI research lab focused on understanding machine intelligence, working on model interpretability, feature geometry, and the mathematics of what large language models learn. It commercializes its interpretability research through products that scale with LLM usage.

4 investors

Matrubials develops antimicrobial peptides derived from milk to create novel therapeutics for bacterial infections, starting with bacterial vaginosis. The company uses AI-enabled technology to identify and validate bioactive molecules for infectious disease treatments.

4 investors

MATSUKO builds holographic communication technology that transmits real people as live 3D holograms (rather than avatars) using a camera and mixed reality devices, including an iPhone app. It is used for remote meetings and holographic training experiences for enterprise clients.

4 investors

Maxterial develops advanced chemicals and coatings, including a coating platform designed to protect surfaces against wear, heat, and corrosion.

4 investors

Melagen Labs develops MLC1, a proprietary hydrogen-based biomaterial polymer composite designed to shield space assets from cosmic and solar radiation for deep space exploration missions. The company offers radiation shielding materials and operates a radiation testing facility for the aerospace industry.

4 investors

Merantix is a Europe-focused group that invests in, builds, and connects artificial intelligence companies and ventures. It operates as an AI venture platform aiming to develop European AI businesses.

4 investors

Beam is a crypto-native innovation lab and ecosystem operating at the intersection of AI, trading, and blockchain, with the $BEAM token serving as its primary currency across Ethereum, Base, and Avalanche. Through six divisions it builds, invests in, and accelerates frontier projects spanning DeFi, decentralized compute, and consumer trading apps for traders, developers, and organizations worldwide.

4 investors

Mesodyne develops patented electricity generation technology, including LightCell, for military and commercial users requiring portable and durable power solutions.

4 investors

Metalware provides autonomous binary security testing for firmware without requiring source code, hardware, or test harnesses. The platform finds vulnerabilities and crashes in embedded systems for automotive, aerospace, medical, and critical infrastructure sectors.

4 investors

MIMOSA Diagnostics develops medical devices and technology to improve healthcare equity through diagnostic solutions. The company focuses on skin and wound healing diagnostics with a team led by experienced medical device engineers and healthcare professionals.

4 investors

An AI research organization that develops interface innovations and neural technologies, focusing on human-AI interaction breakthroughs including neural signal processing and thought decoding methods.

4 investors

Mineral Forecast develops an AI platform for mining exploration that analyzes geoscience data to help identify promising mineral claims and optimize drilling operations. The platform serves geologists and mining executives seeking to accelerate mineral discovery for critical metals needed in the transition to zero-emissions energy.

4 investors

Minutia develops insulin-producing cell transplants that can be monitored in vivo over time, aimed at improving cell replacement therapy for diabetes. The company works in the regenerative medicine and cell therapy field.

4 investors

MMtron designs monolithic microwave integrated circuits (MMICs) with optimized performance across output power, linearity, efficiency, and bandwidth using advanced semiconductor technologies.

4 investors

MOBILion Systems develops the MOBIE platform, a high-resolution ion mobility mass spectrometry (HRIM-MS) instrument that separates and identifies complex molecules in separation science. It serves pharmaceutical, biopharma, academic, and diagnostics labs across cell and gene therapy, therapeutic characterization, food and environmental testing, and biomarker research.

4 investors

Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.

4 investors

Moodify builds an AI-driven "autonomous digital perfumer" that uses Artificial Olfactive Intelligence to translate brand briefs into fragrance formulations, encoding scent perception into smell vectors and generating ranked formulas that account for cost, IFRA compliance, and sustainability. The platform serves fragrance and perfume formulation teams.

4 investors

Moonlake builds a real-to-sim API and world modeling stack that turns an image, video, or text description into physically accurate 3D models with joints, ranges, and drive limits for export to formats like USD, Isaac Sim, and MuJoCo. The product targets enterprise and robotics simulation use cases.

4 investors

Moonware develops software for airfield operations automation, including HALO, a real-time operations control tool for managing ground operations, resources, and scheduling. It serves the passenger, cargo, defense, and advanced air mobility sectors, with additional products for military airbase command-and-control (NOVA) and vertiport coordination (ORION & ATLAS).

4 investors

Multibeam designs and manufactures multi-column electron-beam lithography (MEBL) systems that enable maskless semiconductor production for chipmakers. The systems support rapid prototyping, on-chip security, chiplet integration, and silicon photonics applications.

4 investors

Muna Therapeutics is a biotechnology company developing therapeutics, with a focus on drug discovery involving medicinal chemistry.

4 investors

Myolab develops MyoSapiens, an embodied AI system designed to understand and learn from human full-body movements, behaviors, and interactions by combining embodied behavior data with environmental context and world knowledge.

4 investors

Nanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.

4 investors

Nanobubble Agritech supplies nanobubble technology systems for agricultural irrigation in New Zealand and Australia, designed to improve plant growth, disease resistance, and soil health. The company's solutions enhance water productivity and crop yields for farming operations.

4 investors